Psychopharmacological therapy of deviant sexual behavior.
Psychopharmacological approaches to controlling male deviant sexual behavior, especially sexual recidivism and sexual deviants on probation, have been reported in psychiatric literature. In Europe, the drug cyproterone acetate, and in the United States, medroxyprogesterone acetate, Provera, and in the long-acting form, Depo-Provera, have all benefitted exhibitionists and pedophiliacs, and reduced sex drive in sexual deviants. The combination of pharmacotherapy and either psychotherapy or behavioral therapy has been the most effective approach to reducing the sex drive of sexual deviants.
Murray
J B
JB
Department of Psychology, St. John's University, Jamaica, NY 11439.
D000726:Androgen Antagonists / Q000627:therapeutic use*; D003534:Cyproterone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017373:Cyproterone Acetate; D006801:Humans; D008297:Male; D008525:Medroxyprogesterone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017258:Medroxyprogesterone Acetate; D010262:Paraphilic Disorders / Q000188:drug therapy*
D000726:Androgen Antagonists; D017373:Cyproterone Acetate; D017258:Medroxyprogesterone Acetate; D003534:Cyproterone; D008525:Medroxyprogesterone